Cargando…

Population Pharmacokinetics of Cyclosporine in Chinese Pediatric Patients With Acquired Aplastic Anemia

Cyclosporine (CsA) is a component of the first-line treatment for acquired aplastic anemia (acquired AA) in pediatric patients. This study aimed to develop a population pharmacokinetic (PK) model of CsA in Chinese pediatric patients with acquired AA to inform individual dosage regimens. A total of 6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Xuan, Bian, Zhu-Li, Qiao, Xiao-Hong, Qian, Xiao-Wen, Li, Jun, Shen, Guo-Mei, Miao, Hui, Yu, Yi, Meng, Jian-Hua, Zhu, Xiao-Hua, Jiang, Jun-Ye, Le, Jun, Yu, Ling, Wang, Hong-Sheng, Zhai, Xiao-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377374/ https://www.ncbi.nlm.nih.gov/pubmed/35979231 http://dx.doi.org/10.3389/fphar.2022.933739

Ejemplares similares

Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
por: Gao, Xuan, et al.
Publicado: (2021)

Gut inflammation in the pathogenesis of acquired aplastic anemia
por: Zhao, Xi-Chen, et al.
Publicado: (2020)

Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
por: Xu, Lan-Ping, et al.
Publicado: (2019)

Mass cytometry analysis identifies T cell immune signature of aplastic anemia and predicts the response to cyclosporine
por: Zhang, Lele, et al.
Publicado: (2023)

Acquired aplastic anemia: Is bystander insult to autologous hematopoiesis driven by immune surveillance against malignant cells?
por: Zhao, Xi-Chen, et al.
Publicado: (2020)

APC/C is essential for hematopoiesis and impaired in aplastic anemia
por: Wang, Jia, et al.
Publicado: (2017)

Cyclosporine Monotherapy in Pediatric Patients With Non-severe Aplastic Anemia: A Retrospective Analysis
por: Li, Hongmin, et al.
Publicado: (2022)

Adding cyclosporin A to eltrombopag for aplastic anemia secondary to chemotherapy for solid cancers
por: Wan, Ziqi, et al.
Publicado: (2023)

Cyclosporine monotherapy for severe aplastic anemia: a developing country experience
por: Al-Ghazaly, Jameel, et al.
Publicado: (2005)

Effective treatment of aplastic anemia secondary to chemoradiotherapy using cyclosporine A
por: Ruan, Jing, et al.
Publicado: (2021)

An investigation of long-term outcome of rabbit anti-thymocyte globulin and cyclosporine therapy for pediatric severe aplastic anemia
por: Chang, Lixian, et al.
Publicado: (2023)

Chinese Herbal Medicine Therapy Reduces the Risks of Overall and Anemia-Related Mortalities in Patients With Aplastic Anemia: A Nationwide Retrospective Study in Taiwan
por: Chiu, Mu-Lin, et al.
Publicado: (2021)

Fatal Epstein-Barr Virus Reactivation in an Acquired Aplastic Anemia Patient Treated with Rabbit Antithymocyte Globulin and Cyclosporine A
por: Takahashi, Tohru, et al.
Publicado: (2015)

Population pharmacokinetic analysis, renal safety, and dosing optimization of polymyxin B in lung transplant recipients with pneumonia: A prospective study
por: Cai, Xiao-Jun, et al.
Publicado: (2022)

Population Pharmacokinetics and Initial Dosage Optimization of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Patients
por: Liu, Xiao-Lin, et al.
Publicado: (2022)

Intraperitoneal Injection of Multiplacentas Pooled Cells Treatment on a Mouse Model with Aplastic Anemia
por: Li, Jun, et al.
Publicado: (2016)

Mesenchymal Stem Cells in Acquired Aplastic Anemia: The Spectrum from Basic to Clinical Utility
por: Wang, Xing-An, et al.
Publicado: (2023)

Relationship of Cell Compositions in Allografts with Outcomes after Haploidentical Transplantation for Acquired Severe Aplastic Anemia: Effects of CD34(+) and CD14(+) Cell Doses
por: Cao, Le-Qing, et al.
Publicado: (2018)

Immunosuppressive Treatment in Children with Acquired Aplastic Anemia
por: Yıldırmak, Yıldız, et al.
Publicado: (2012)

Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant
por: Xu, Lan-Ping, et al.
Publicado: (2017)

Population Pharmacokinetics of Vancomycin in Chinese ICU Neonates: Initial Dosage Recommendations
por: Li, Zhi-ling, et al.
Publicado: (2018)

Population Pharmacokinetics of Colistin Sulfate in Critically Ill Patients: Exposure and Clinical Efficacy
por: Yu, Xu-ben, et al.
Publicado: (2022)

Correlation of the Plasma Concentration of Eltrombopag With Efficacy in the Treatment of Refractory Aplastic Anemia: A Single-Centre Study in China
por: Zuo, Wei, et al.
Publicado: (2020)

Immunomodulation Therapy for Severe Aplastic Anemia: —ALG Versus ALG Plus Cyclosporin A—
por: Park, Chong Won, et al.
Publicado: (1989)

Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia
por: Zhao, Yufei, et al.
Publicado: (2023)

P792: CLINICAL STUDY OF HETROMBOPAG COMBINED WITH CYCLOSPORINE A IN THE TREATMENT OF CHILDREN WITH NON-SEVERE APLASTIC ANEMIA
por: Chang, Lixian, et al.
Publicado: (2023)

THPO gene variants in patients with acquired aplastic anemia
por: Padilha, Pedro Henrique, et al.
Publicado: (2018)

Prospective population pharmacokinetic study of tacrolimus in adult recipients early after liver transplantation: A comparison of Michaelis-Menten and theory-based pharmacokinetic models
por: Cai, Xiao-Jun, et al.
Publicado: (2022)

P1335: REPAIR OF DYSFUNCTIONAL BONE MARROW ENDOTHELIAL CELLS ALLEVIATES APLASTIC ANEMIA
por: Tang, Shu-Qian, et al.
Publicado: (2023)

Dysregulated miR34a/diacylglycerol kinase ζ interaction enhances T-cell activation in acquired aplastic anemia
por: Sun, Yuan-xin, et al.
Publicado: (2016)

Cyclosporine Therapy in Patients with Transfusion-independent Non-severe Aplastic Anemia: A Retrospective Analysis
por: Matsuda, Kensuke, et al.
Publicado: (2018)

Excellent response of severe aplastic anemia to treatment of gut inflammation: A case report and review of the literature
por: Zhao, Xi-Chen, et al.
Publicado: (2020)

Allogeneic Bone Marrow‐Derived Mesenchymal Stromal Cells Expanded In Vitro for Treatment of Aplastic Anemia: A Multicenter Phase II Trial
por: Pang, Yan, et al.
Publicado: (2017)

The Correlation Between Busulfan Exposure and Clinical Outcomes in Chinese Pediatric Patients: A Population Pharmacokinetic Study
por: Du, Xiaohuan, et al.
Publicado: (2022)

Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children
por: Li, Jun, et al.
Publicado: (2016)

I(K1) Channel Agonist Zacopride Alleviates Cardiac Hypertrophy and Failure via Alterations in Calcium Dyshomeostasis and Electrical Remodeling in Rats
por: Liu, Qing-Hua, et al.
Publicado: (2019)

Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment
por: Medinger, Michael, et al.
Publicado: (2018)

The Effect of Posaconazole and Isavuconazole on the Pharmacokinetics of Erdafitinib in Beagle Dogs by UPLC-MS/MS
por: Ruan, Lan-hong, et al.
Publicado: (2021)

Association between haploidentical hematopoietic stem cell transplantation combined with an umbilical cord blood unit and graft-versus-host disease in pediatric patients with acquired severe aplastic anemia
por: Yao, Di, et al.
Publicado: (2022)

Effective Tacrolimus Treatment for Patients with Non-Severe Aplastic Anemia That is Refractory/Intolerant to Cyclosporine A: A Retrospective Study
por: Du, Yali, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kqge8s668vvl2l8a9lfa85frru